Table 1. Characteristics of the study population.
Case | Age | Gender | Duration of diabetes | HBA1c | Diagnosis | BCVA (Snellen) |
---|---|---|---|---|---|---|
DM1_P1 | 37 | F | 21 | 7.2 | NPDR | 1.0 |
DM1_P2 | 35 | F | 17 | 6.1 | NPDR | 1.0 |
DM1_P3 | 32 | M | 16 | 8.2 | NPDR | 1.0 |
DM1_P4 | 35 | F | 10 | 6.8 | NPDR | 1.2 |
DM1_P5 | 50 | F | 13 | 7.2 | NPDR | 1.0 |
DM1_P6 | 48 | M | 11 | 7.9 | NPDR | 1.0 |
DM1_P7 | 55 | F | 37 | 7.0 | NPDR | 1.0 |
DM1_P8 | 51 | M | 18 | 8.0 | NPDR | 1.0 |
DM1_P9 | 35 | F | 9 | 6.3 | noDR | 1.2 |
DM1_P10 | 46 | M | 9 | 8.9 | noDR | 1.0 |
DM1_P11 | 39 | M | 12 | 7.0 | noDR | 1.2 |
DM1_P12 | 36 | M | 11 | 8.2 | noDR | 1.2 |
DM1_P13 | 30 | M | 8 | 7.6 | noDR | 1.2 |
DM1_P14 | 36 | F | 9 | 7.0 | noDR | 1.0 |
DM1_P15 | 47 | M | 12 | 8.0 | noDR | 1.2 |
DM1_P16 | 29 | F | 14 | 8.0 | noDR | 1.0 |
C30 | 29 | F | - | - | Control | 1.0 |
C31 | 27 | F | - | - | Control | 1.2 |
C32 | 28 | F | - | - | Control | 1.2 |
C33 | 34 | M | - | - | Control | 1.0 |
C34 | 28 | M | - | - | Control | 1.2 |
C35 | 29 | F | - | - | Control | 1.2 |
C36 | 40 | F | - | - | Control | 1.0 |
C37 | 39 | F | - | - | Control | 1.0 |
C38 | 28 | F | - | - | Control | 1.2 |
C39 | 42 | M | - | - | Control | 1.2 |
C40 | 27 | F | - | - | Control | 1.0 |
C41 | 47 | M | - | - | Control | 1.2 |
C42 | 30 | F | - | - | Control | 1.0 |
C43 | 36 | M | - | - | Control | 1.2 |
C44 | 39 | F | - | - | Control | 1.0 |
C45 | 33 | M | - | - | Control | 1.2 |
C46 | 56 | M | - | - | Control | 1.0 |
C47 | 44 | F | - | - | Control | 1.0 |
C48 | 52 | F | - | - | Control | 1.0 |
C49 | 38 | F | - | - | Control | 1.2 |
HBA1c = glycohemoglobin serum level; BCVA = Best Corrected Visual Acuity